Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMIVANTAMAB Cause Hypersensitivity? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hypersensitivity have been filed in association with AMIVANTAMAB (Rybrevant). This represents 0.9% of all adverse event reports for AMIVANTAMAB.

7
Reports of Hypersensitivity with AMIVANTAMAB
0.9%
of all AMIVANTAMAB reports
2
Deaths
4
Hospitalizations

How Dangerous Is Hypersensitivity From AMIVANTAMAB?

Of the 7 reports, 2 (28.6%) resulted in death, 4 (57.1%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for AMIVANTAMAB.

What Other Side Effects Does AMIVANTAMAB Cause?

Infusion related reaction (62) Rash (61) Pulmonary embolism (41) Dermatitis acneiform (34) Thrombocytopenia (33) Paronychia (29) Diarrhoea (25) Pneumonitis (24) Dyspnoea (23) Nausea (23)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which AMIVANTAMAB Alternatives Have Lower Hypersensitivity Risk?

AMIVANTAMAB vs AMIVANTAMAB-VMJW AMIVANTAMAB vs AMLODIPINE AMIVANTAMAB vs AMLODIPINE BESILATE AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL

Related Pages

AMIVANTAMAB Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity AMIVANTAMAB Demographics